Key Takeaways
- • KBRA disputes Columbia Business School's findings on private ratings risk in US life insurers, arguing the academic study overstates both the scale and regulatory impact of the issue in a June 9 research note titled "Private Credit: Much Ado About Nothing."
- • The Columbia paper concluded that privately rated bonds held by life insurers understate credit risk compared to public ratings and generate lower regulatory capital requirements, despite experiencing higher impairment rates post-issuance.
- • KBRA calculates the Columbia study's own quantitative findings imply only approximately $4 billion in additional required capital for the entire US life insurance industry—representing 0.5% of industry total adjusted capital and less than 0.1% of invested assets.
- • The methodological dispute centers on the gap between Columbia's headline conclusions and its empirical data, with KBRA asserting the paper's policy recommendations are disproportionate to its quantitative support.
- • The debate highlights ongoing regulatory and transparency concerns surrounding the growing use of private credit instruments in institutional insurance portfolios and the adequacy of rating methodologies for non-public securities.
Summary
Kroll Bond Rating Agency (KBRA) has challenged the conclusions of a recent Columbia Business School study examining private ratings' role in US life insurers' capital adequacy, contending that the academic research overstates both the magnitude of rating inflation and its regulatory implications. In a June 9 research note, KBRA argued that while the Columbia paper raises legitimate questions about transparency and risk measurement in private credit markets, the study's broader policy conclusions exceed what its own quantitative findings support.
The Columbia Business School paper, titled "Rating Without Market Discipline," examined the rapid expansion of privately rated bonds in US life insurers' portfolios and found that private ratings tend to understate credit risk relative to public ratings. The researchers documented that privately rated securities experienced higher subsequent impairment rates and generated lower regulatory capital requirements than similarly designated publicly rated securities, raising concerns about potential undercapitalization within the insurance sector.
However, KBRA's rebuttal focuses on the magnitude of the problem identified. According to KBRA's analysis, even accepting all of Columbia's analytical assumptions and inferential steps as valid, the authors' own illustrative capital exercise implies approximately $4 billion in additional required capital for the entire US life insurance industry. KBRA characterized this figure as modest relative to industry scale: 0.5% of industry total adjusted capital, 0.6% of industry surplus, and less than 0.1% of invested assets. This framing suggests the regulatory risk, while present, may be more contained than Columbia's headline findings imply.
The dispute underscores methodological tensions in assessing private credit risk within regulated insurance portfolios. KBRA's position indicates that while private rating inflation warrants scrutiny from regulators and market participants, the quantified impact may not justify the level of policy concern Columbia's conclusions suggest. The disagreement is relevant for institutional investors and family offices evaluating exposure to life insurance company investments and for understanding potential regulatory responses to private credit proliferation within insurance balance sheets.
The Columbia Business School paper, titled "Rating Without Market Discipline," examined the rapid expansion of privately rated bonds in US life insurers' portfolios and found that private ratings tend to understate credit risk relative to public ratings. The researchers documented that privately rated securities experienced higher subsequent impairment rates and generated lower regulatory capital requirements than similarly designated publicly rated securities, raising concerns about potential undercapitalization within the insurance sector.
However, KBRA's rebuttal focuses on the magnitude of the problem identified. According to KBRA's analysis, even accepting all of Columbia's analytical assumptions and inferential steps as valid, the authors' own illustrative capital exercise implies approximately $4 billion in additional required capital for the entire US life insurance industry. KBRA characterized this figure as modest relative to industry scale: 0.5% of industry total adjusted capital, 0.6% of industry surplus, and less than 0.1% of invested assets. This framing suggests the regulatory risk, while present, may be more contained than Columbia's headline findings imply.
The dispute underscores methodological tensions in assessing private credit risk within regulated insurance portfolios. KBRA's position indicates that while private rating inflation warrants scrutiny from regulators and market participants, the quantified impact may not justify the level of policy concern Columbia's conclusions suggest. The disagreement is relevant for institutional investors and family offices evaluating exposure to life insurance company investments and for understanding potential regulatory responses to private credit proliferation within insurance balance sheets.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.